Core Viewpoint - On August 21, 2025, a drying equipment explosion occurred at Guilin Rhein Biotechnology Co., Ltd., resulting in 1 death and multiple injuries. The company is cooperating with government authorities for emergency response and investigation [1][5]. Incident Summary - The explosion took place in a drying workshop, leading to 1 fatality, 3 serious injuries, and 4 minor injuries. The company activated its emergency response plan and formed a leadership group for on-site management [1][5]. - Initial estimates indicate property damage of approximately 2 million yuan (around 0.29 million USD) due to the incident. However, the company stated that this accident would not significantly impact its future operations [1][5]. Company Profile - Guilin Rhein Biotechnology is a leading enterprise in the global plant extraction industry and the first listed company in China's plant extraction sector. The company specializes in the research, production, and sales of natural health products [5]. Financial Performance - In the first quarter of 2025, the company reported revenue of 444 million yuan (approximately 63.5 million USD), representing a year-on-year increase of 30.21%. The net profit attributable to shareholders was 30.8 million yuan (around 4.4 million USD), up 14.95% year-on-year [6]. Stock Market Reaction - Following the incident, the company's stock price fell by 4.44%, closing at 8.18 yuan per share, with a total market capitalization of 6.1 billion yuan (approximately 861 million USD) [7][8].

【"一公里外听到爆炸声" #广西桂林一公司设备爆炸1死7伤# 涉事企业官网已变灰】#广西一公司回应设 备爆炸1死7伤#8月21日，广西桂林临桂区一公司车间发生设备爆炸，造成1死7伤。@新京报 记者核实 获悉，事发公司为广西桂林莱茵生物（维权）科技股份有限公司。周边居民称，事发车间位于厂区内 部，凌晨五点多居民曾在附近听到爆炸声。莱茵生物总部工作人员告诉记者，目前公司仍在正常经营。 该工作人员称，遇难者和伤者的安置工作由专人负责，事故原因仍在调查中。 ...

Core Viewpoint - An explosion occurred at a facility of Guangxi Guilin Rhine Biotechnology Co., Ltd., resulting in one death and seven injuries [1] Company Summary - The incident took place in the early morning hours, with residents hearing the explosion around 5 AM [1] - The company confirmed that it is still operating normally despite the incident [1] - The company has assigned personnel to manage the arrangements for the deceased and injured [1] - The cause of the explosion is currently under investigation [1]

Group 1 - The company, Rhein Biotech, stated on August 21 that its main products focus on functional ingredients and it currently has no plans for large-scale production of natural pigments [2]

Core Viewpoint - The company plans to permanently supplement its working capital with surplus funds from completed investment projects, aiming to alleviate financial pressure and optimize its financial structure [2][3]. Group 1: Board Meeting Details - The seventh board meeting was held on August 20, 2025, with all seven participating directors present, ensuring compliance with relevant laws and regulations [2]. - The board made several resolutions, including the conclusion of the "Stevia Professional Extraction Factory Construction Project" and the "Rhein Natural Health Products Research Institute Construction Project" [2][3]. Group 2: Financial Decisions - The company intends to use a total of 315.34 million yuan from surplus funds and estimated outstanding project payments to permanently supplement its working capital [2][3]. - The board believes that this move will help ease financial pressure, optimize the financial structure, and enhance the company's risk resistance capabilities [3]. Group 3: Financing Initiatives - The company plans to engage in financing leaseback transactions with qualified leasing institutions, with a total financing amount not exceeding 300 million yuan [3]. - A temporary shareholders' meeting is scheduled for September 9, 2025, to discuss further corporate matters [3][4].

Group 1 - The company held its seventh supervisory board's fifth meeting on August 20, 2025, which was conducted via telecommunication and was attended by all supervisory members and executives [2][4]. - The supervisory board unanimously agreed to reduce the investment scale of certain fundraising projects, conclude some fundraising projects, and permanently supplement the remaining raised funds into working capital [3][4]. - The decision to reduce the investment scale and conclude projects is based on the company's current situation and aims to improve the efficiency of fund usage and lower financial costs, benefiting the company and all shareholders, particularly minority shareholders [2][3]. Group 2 - The meeting was legally valid and complied with the Company Law of the People's Republic of China and the company's articles of association [2]. - The company will publish detailed information regarding the reduction of fundraising investment scale and the conclusion of projects in major financial newspapers and platforms [3][4].

Meeting Information - The company will hold its first extraordinary general meeting of shareholders in 2025 on September 9, 2025, at 15:00 [2] - Network voting will be available on the same day from 9:15 to 15:00 through the Shenzhen Stock Exchange trading system and internet voting system [2][3] Voting Procedures - Shareholders can choose between on-site voting and network voting, with the first vote counted in case of duplicate votes [3] - All ordinary shareholders registered by the close of business on September 3, 2025, are eligible to attend and vote [3][4] Agenda Items - The meeting will review a proposal to reduce the scale of certain fundraising investments, conclude fundraising projects, and permanently supplement working capital with surplus funds [3][4] - The proposal has already been approved by the company's board and supervisory committee [3] Registration and Participation - Natural persons must present valid identification and shareholding certificates for registration [6] - Legal entities must provide a copy of the business license, shareholding certificates, and authorization letters for their representatives [6] - Remote shareholders can register via mail, fax, or letter [6] Voting Process - The voting will be a non-cumulative voting process, allowing shareholders to express their opinions as agree, disagree, or abstain [7] - Specific procedures for voting through the Shenzhen Stock Exchange systems are outlined in the meeting documents [7]

Core Viewpoint - A drying equipment explosion occurred at Rhine Biotech on August 21, 2025, resulting in one death and multiple injuries, with ongoing investigations into the cause of the incident [1] Incident Summary - The explosion took place in a drying workshop, leading to one fatality, three serious injuries, and four minor injuries [1] - The company is cooperating with government authorities for the treatment of the injured and the investigation of the incident [1] Financial Impact - Preliminary estimates indicate property damage of approximately 2 million yuan due to the explosion [1] - The incident is not expected to have a significant adverse impact on the company's future production and operations [1] Production Process - The company's plant extraction process includes several stages: pretreatment, extraction, separation, purification, concentration, drying, and packaging [1]

Core Viewpoint - A drying equipment explosion occurred at Rhine Biotech on August 21, 2025, resulting in one death and multiple injuries, with ongoing investigations into the cause [1] Incident Summary - The explosion took place in a drying workshop at 5:40 AM, leading to 1 fatality, 3 serious injuries, and 4 minor injuries [1] - The company is cooperating with government authorities for the treatment of the injured and the investigation of the incident [1] Financial Impact - Preliminary estimates indicate property damage of approximately 2 million yuan due to the explosion [1] - The incident is not expected to have a significant adverse impact on the company's future operations [1] Production Process - The company's production process includes several stages: pretreatment, extraction, separation, purification, concentration, drying, and packaging [1] - The explosion occurred in one of the drying workshops, affecting that specific area and its equipment [1]

Core Viewpoint - The explosion at a drying facility of Rhine Biotech (002166.SZ) resulted in one fatality and multiple injuries, but the company asserts that it will not significantly impact future operations [1] Incident Summary - On August 21, 2025, an explosion occurred at a drying equipment in one of the company's facilities, leading to one death, three serious injuries, and four minor injuries [1] - The preliminary assessment indicates property damage of approximately 2 million yuan [1] Company Response - The company plans to conduct a comprehensive safety inspection and implement measures to prevent future incidents [1]